
Image: TechCrunch
Discover how Mave Health's neuromodulation headset aims to boost mood and attention without needing FDA clearance. Learn more about its groundbreaking approach.
GlipzoThe founders, Dhawal Jain, Jai Sharma, and Aman Kumar, recognized a pressing need for innovative solutions in mental health after a personal tragedy during the COVID-19 pandemic. Jain's experience with a friend's suicide highlighted the gaps in mental health support and measurement. "In India, committing suicide is a crime, which meant there was police involved, and we had to speak to her psychologist. The answers we got from them made us question if any of it made sense," Jain recounted. This pivotal moment led to the creation of a device aimed at providing measurable insights into mental health progress.
In preliminary testing, more than 500 private beta users reported significant improvements, with 80% indicating a 60% boost in productivity and 75% noting a reduction in stress levels within two months of using the headset. Although clinical trials are yet to be published, these findings suggest promising potential for Mave Health’s neuromodulation device.
Mave Health has conducted four observational studies involving 200 participants, currently under academic review, with plans to publish findings later this year. These studies aim to substantiate the device’s effectiveness and its role in everyday mental wellness.
This shift not only empowers users but also raises significant questions about the future of mental health treatment. Will technology replace traditional therapy, or will it complement existing methods? As Mave Health seeks to expand its reach, the mental health community will be watching closely to see how this innovative approach unfolds.
This development is a critical step towards making mental health support more accessible, blending technology with personal well-being for a potentially transformative effect. As we monitor the evolution of Mave Health's headset, its impact on mental health practices and user experiences could inspire similar innovations in the field.

Shocking findings from Nottingham's maternity unit reveal a toxic culture and alarming neglect. What can be done to improve care? Discover the details.
BBC Health
Discover how daraxonrasib, a new pill, is nearly doubling survival rates for pancreatic cancer patients, offering hope in a challenging battle against this deadly disease.
BBC Health
Waste companies propose a £5 deposit on vapes to encourage proper disposal and curb littering as the environmental impact of vapes increases.
BBC Business